632 related articles for article (PubMed ID: 19681719)
1. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
[TBL] [Abstract][Full Text] [Related]
2. A prospective analysis of immunohistochemically determined estrogen receptor alpha and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog.
de Las Mulas JM; Millán Y; Dios R
Vet Pathol; 2005 Mar; 42(2):200-12. PubMed ID: 15753474
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and progesterone receptor status of mammary carcinomas and correlation with clinical outcome in dogs.
Sartin EA; Barnes S; Kwapien RP; Wolfe LG
Am J Vet Res; 1992 Nov; 53(11):2196-200. PubMed ID: 1466519
[TBL] [Abstract][Full Text] [Related]
4. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
[TBL] [Abstract][Full Text] [Related]
5. Receptors for oestrogen, progesterone and epidermal growth factor in normal and tumorous canine mammary tissues.
Donnay I; Rauïs J; Wouters-Ballman P; Devleeschouwer N; Leclercq G; Verstegen JP
J Reprod Fertil Suppl; 1993; 47():501-12. PubMed ID: 8229969
[TBL] [Abstract][Full Text] [Related]
6. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors.
Lee CH; Kim WH; Lim JH; Kang MS; Kim DY; Kweon OK
J Vet Sci; 2004 Mar; 5(1):63-9. PubMed ID: 15028887
[TBL] [Abstract][Full Text] [Related]
7. Studies on canine mammary tumours. II. Oestradiol and progesterone receptor binding capacity and histological type.
Boldizsár H; Muray T; Számel I; Szenci O; Csenki J
Acta Vet Hung; 1992; 40(1-2):89-97. PubMed ID: 1476094
[TBL] [Abstract][Full Text] [Related]
8. Comparison of estrogen and progesterone receptor expression in normal and tumor mammary tissues from dogs.
Donnay I; Rauïs J; Devleeschouwer N; Wouters-Ballman P; Leclercq G; Verstegen J
Am J Vet Res; 1995 Sep; 56(9):1188-94. PubMed ID: 7486397
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of estrogen receptor beta in normal and tumoral canine mammary glands.
Martín de las Mulas J; Ordás J; Millán MY; Chacón F; De Lara M; Espinosa de los Monteros A; Reymundo C; Jover A
Vet Pathol; 2004 May; 41(3):269-72. PubMed ID: 15133176
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-9 expression in mammary gland tumors in dogs and its relationship with prognostic factors and patient outcome.
Santos AA; Lopes CC; Marques RM; Amorim IF; Gärtner MF; de Matos AJ
Am J Vet Res; 2012 May; 73(5):689-97. PubMed ID: 22533401
[TBL] [Abstract][Full Text] [Related]
11. Morphological and immunohistochemical characterization of spontaneous mammary gland tumors in the guinea pig (Cavia porcellus).
Suárez-Bonnet A; Martín de Las Mulas J; Millán MY; Herráez P; Rodríguez F; Espinosa de los Monteros A
Vet Pathol; 2010 Mar; 47(2):298-305. PubMed ID: 20106793
[TBL] [Abstract][Full Text] [Related]
12. The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours.
Ferreira E; Bertagnolli AC; Cavalcanti MF; Schmitt FC; Cassali GD
Vet Comp Oncol; 2009 Dec; 7(4):230-5. PubMed ID: 19891693
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous mammary intraepithelial lesions in dogs--a model of breast cancer.
Antuofermo E; Miller MA; Pirino S; Xie J; Badve S; Mohammed SI
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2247-56. PubMed ID: 17982119
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
Gama A; Alves A; Schmitt F
Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: a survival study.
Santos A; Lopes C; Frias C; Amorim I; Vicente C; Gärtner F; Matos Ad
Vet J; 2011 Dec; 190(3):396-402. PubMed ID: 21269852
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathological prognostic factors in canine mammary tumors.
Pérez Alenza MD; Peña L; Nieto AI; Castaño M
Ann Ist Super Sanita; 1997; 33(4):581-5. PubMed ID: 9616968
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical staining of metallothionein in canine mammary tumors: better survival with higher expression.
Cardoso SV; Caliari MV; de Aguiar MC; Cassali GD
Oncol Rep; 2004 Dec; 12(6):1317-21. PubMed ID: 15547757
[TBL] [Abstract][Full Text] [Related]
18. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptors in canine mammary gland tumours.
Sobczak-Filipiak M; Malicka E
Pol J Vet Sci; 2002; 5(1):1-5. PubMed ID: 11944580
[TBL] [Abstract][Full Text] [Related]
20. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
